Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

The combination of nuclear and mitochondrial mutations as a risk factor for idiosyncratic toxicity.

LaRocca D, Lehmann DF, Perl A, Ozawa T, Holohan PD.

Br J Clin Pharmacol. 2007 Feb;63(2):249-51. Epub 2006 Aug 30. No abstract available.

2.

Association between conformational mutations in neuroserpin and onset and severity of dementia.

Davis RL, Shrimpton AE, Carrell RW, Lomas DA, Gerhard L, Baumann B, Lawrence DA, Yepes M, Kim TS, Ghetti B, Piccardo P, Takao M, Lacbawan F, Muenke M, Sifers RN, Bradshaw CB, Kent PF, Collins GH, Larocca D, Holohan PD.

Lancet. 2002 Jun 29;359(9325):2242-7. Erratum in: Lancet 2002 Oct 5;360(9339):1102.

PMID:
12103288
3.

Cognitive deficits associated with a recently reported familial neurodegenerative disease: familial encephalopathy with neuroserpin inclusion bodies.

Bradshaw CB, Davis RL, Shrimpton AE, Holohan PD, Rea CB, Fieglin D, Kent P, Collins GH.

Arch Neurol. 2001 Sep;58(9):1429-34.

PMID:
11559315
4.

Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy.

Takao M, Benson MD, Murrell JR, Yazaki M, Piccardo P, Unverzagt FW, Davis RL, Holohan PD, Lawrence DA, Richardson R, Farlow MR, Ghetti B.

J Neuropathol Exp Neurol. 2000 Dec;59(12):1070-86.

PMID:
11138927
5.

Familial encephalopathy with neuroserpin inclusion bodies.

Davis RL, Holohan PD, Shrimpton AE, Tatum AH, Daucher J, Collins GH, Todd R, Bradshaw C, Kent P, Feiglin D, Rosenbaum A, Yerby MS, Shaw CM, Lacbawan F, Lawrence DA.

Am J Pathol. 1999 Dec;155(6):1901-13.

6.

Familial dementia caused by polymerization of mutant neuroserpin.

Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, Feiglin D, Collins GH, Sonderegger P, Kinter J, Becker LM, Lacbawan F, Krasnewich D, Muenke M, Lawrence DA, Yerby MS, Shaw CM, Gooptu B, Elliott PR, Finch JT, Carrell RW, Lomas DA.

Nature. 1999 Sep 23;401(6751):376-9.

PMID:
10517635
7.

Evidence that the organic cation/H+ exchanger in the brush border membrane of dog kidney is a 41-kDa protein.

Gilsdorf JS, Rebbeor JF, Holohan PD.

J Pharmacol Exp Ther. 1997 Feb;280(2):1043-50.

PMID:
9023322
8.
9.

Photoaffinity labeling of the organic cation/H+ exchanger in renal brush border membrane vesicles.

Holohan PD, White KE, Sokol PP, Rebbeor J.

J Biol Chem. 1992 Jul 5;267(19):13513-9.

10.

Cyclosporin A and vehicle toxicity in primary cultures of rabbit renal proximal tubule cells.

Sokol PP, Capodagli LC, Dixon M, Holohan PD, Ross CR, Coulson R, Jones DB.

Am J Physiol. 1990 Dec;259(6 Pt 1):C897-903.

PMID:
2260640
11.

Acridine orange transport in canine renal brush-border membrane vesicles.

Sokol PP, Holohan PD, Ross CR.

Biochem Pharmacol. 1990 Sep 15;40(6):1421-4. No abstract available.

PMID:
2144964
12.

Transepithelial acidification by cultures of rabbit proximal tubules grown on filters.

Ford SM, Williams PD, Grassl S, Holohan PD.

Am J Physiol. 1990 Jul;259(1 Pt 1):C103-9.

PMID:
2372045
13.

Gentamicin and verapamil compete for a common transport mechanism in renal brush border membrane vesicles.

Sokol PP, Huiatt KR, Holohan PD, Ross CR.

J Pharmacol Exp Ther. 1989 Dec;251(3):937-42. Erratum in: J Pharmacol Exp Ther 1990 May;253(2):i.

PMID:
2532251
14.

Operational modes of the organic anion exchanger in canine renal brush-border membrane vesicles.

Steffens TG, Holohan PD, Ross CR.

Am J Physiol. 1989 Apr;256(4 Pt 2):F596-609.

PMID:
2468296
15.

Gentamicin-induced increases in cytosolic calcium in pig kidney cells (LLC-PK1).

Holohan PD, Sokol PP, Ross CR, Coulson R, Trimble ME, Laska DA, Williams PD.

J Pharmacol Exp Ther. 1988 Oct;247(1):349-54.

PMID:
3171979
16.

Mechanism of ochratoxin A transport in kidney.

Sokol PP, Ripich G, Holohan PD, Ross CR.

J Pharmacol Exp Ther. 1988 Aug;246(2):460-5.

PMID:
2969975
17.
18.

Proton-coupled organic cation transport in renal brush-border membrane vesicles.

Sokol PP, Holohan PD, Grassl SM, Ross CR.

Biochim Biophys Acta. 1988 May 24;940(2):209-18. Erratum in: Biochim Biophys Acta 1988 Aug 18;943(2):387. Grass SM [corrected to Grassl SM].

PMID:
2453210
19.

Cl(-)-HCO3- exchange in rat renal basolateral membrane vesicles.

Grassl SM, Holohan PD, Ross CR.

Biochim Biophys Acta. 1987 Dec 11;905(2):475-84.

PMID:
3689790
20.

Effect of parathyroid hormone on gentamicin plasma membrane binding and tissue accumulation.

Holohan PD, Elliott WC, Grace E, Ross CR.

J Pharmacol Exp Ther. 1987 Dec;243(3):893-6.

PMID:
3694535
21.

Organic cation secretion in flounder renal tissue.

Miller DS, Holohan PD.

Am J Physiol. 1987 Dec;253(6 Pt 2):R861-7.

PMID:
2962510
22.

N,N'-dicyclohexylcarbodiimide inactivates organic cation transport in renal brush border membranes.

Sokol PP, Holohan PD, Ross CR.

J Pharmacol Exp Ther. 1987 Nov;243(2):455-9.

PMID:
2824745
24.

HCO3- transport in basolateral membrane vesicles isolated from rat renal cortex.

Grassl SM, Holohan PD, Ross CR.

J Biol Chem. 1987 Feb 25;262(6):2682-7.

25.

Sulfhydryl groups are essential for organic anion exchange in canine renal brush-border membranes.

Sokol PP, Holohan PD, Ross CR.

Biochim Biophys Acta. 1986 Nov 17;862(2):335-42.

PMID:
3022810
26.
27.

Electroneutral transport of organic cations in canine renal brush border membrane vesicles (BBMV).

Sokol PP, Holohan PD, Ross CR.

J Pharmacol Exp Ther. 1985 Jun;233(3):694-9.

PMID:
3159885
28.

Inhibition of renal Na+, K+-adenosine triphosphatase by gentamicin.

Williams PD, Trimble ME, Crespo L, Holohan PD, Freedman JC, Ross CR.

J Pharmacol Exp Ther. 1984 Nov;231(2):248-53.

PMID:
6092609
29.

Na+ gradient-dependent p-aminohippurate (PAH) transport in rat basolateral membrane vesicles.

Kasher JS, Holohan PD, Ross CR.

J Pharmacol Exp Ther. 1983 Oct;227(1):122-9.

PMID:
6312013
30.

Effect of cephaloridine on the transport of organic ions in dog kidney plasma membrane vesicles.

Kasher JS, Holohan PD, Ross CR.

J Pharmacol Exp Ther. 1983 Jun;225(3):606-10.

PMID:
6223134
31.

Transport of organic anions and cations in isolated renal plasma membranes.

Ross CR, Holohan PD.

Annu Rev Pharmacol Toxicol. 1983;23:65-85. Review. No abstract available.

PMID:
6347056
32.

Gentamicin nephrotoxicity. II. Plasma membrane changes.

Williams PD, Holohan PD, Ross CR.

Toxicol Appl Pharmacol. 1981 Nov;61(2):243-51. No abstract available.

PMID:
6275572
33.

Gentamicin nephrotoxicity. I. Acute biochemical correlates in rats.

Williams PD, Holohan PD, Ross CR.

Toxicol Appl Pharmacol. 1981 Nov;61(2):234-42. No abstract available.

PMID:
6275571
34.

Mechanisms of organic cation transport in kidney plasma membrane vesicles: 2. delta pH studies.

Holohan PD, Ross CR.

J Pharmacol Exp Ther. 1981 Feb;216(2):294-8.

PMID:
6450830
35.
36.
37.

Transport of organic ions in renal cortical luminal and antiluminal membrane vesicles.

Kinsella JL, Holohan PD, Pessah NI, Ross CR.

J Pharmacol Exp Ther. 1979 Jun;209(3):443-50.

PMID:
155742
38.

Isolation of luminal and antiluminal membranes from dog kidney cortex.

Kinsella JL, Holohan PD, Pessah NI, Ross CR.

Biochim Biophys Acta. 1979 Apr 19;552(3):468-77.

PMID:
221018
40.

The purification of an organic cation-specific binding protein from dog kidney.

Holohan PD, Pessah NI, Warkentin D, Ross CR.

Mol Pharmacol. 1976 May;12(3):494-503. No abstract available.

PMID:
132605
41.

Binding of N1-methylnicotinamide and p-aminohippuric acid to a particulate fraction from dog kidney.

Holohan PD, Pessah NI, Ross CR.

J Pharmacol Exp Ther. 1975 Oct;195(1):22-33.

PMID:
241840
42.

Molecular weight determinations by low-speed sedimentation equilibrium. A combined use of the Nazarian equation and the Griffth rapid equilibrium technique.

DiCamelli RF, Holohan PD, Basinger SF, Lebowitz J.

Anal Biochem. 1970 Aug;36(2):470-94. No abstract available.

PMID:
5465691

Supplemental Content

Loading ...
Support Center